The Valley Desk

ArticleMolecular therapy oncolyticsPublished

Multivalent in vivo delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escape

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania, The Wistar Institute. Affiliation source

Publication record

Type
Article
Venue
Molecular therapy oncolytics
Published
Subject terms
Bispecific antibody; Immunotherapy; Immune escape; DNA delivery; Glioblastoma Multiforme; Her2; Egfrviii; Heterogeneous Tumor Model; Dual Tumor Antigen Targeting
PubMed ID
36915911
PubMed Central ID
PMC10006507
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal